<DOC>
	<DOCNO>NCT02774616</DOCNO>
	<brief_summary>Post-Market Clinical Follow-up new Ilivia ICD Family new Plexa right ventricular lead fulfill requirement notify body support regulatory approval outside CE region</brief_summary>
	<brief_title>Master Study Ilivia ICD Family Plexa ICD Lead</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Tachycardia</mesh_term>
	<criteria>Standard indication ICD CRTD therapy accord clinical practice De novo implantation upgrade/exchange ( group A ) exist ICD , CRTD pacemaker implant Patient able understand nature clinical investigation provide write informed consent Patient able willing complete routine study visit investigational site Patient accept Home Monitoring concept Age â‰¥ 18 year Contraindication ICD CRTD therapy , respectively For CRTD patient group A : physician willing activate MultiPole Pacing patient Cardiac surgical procedure plan within 6 month implantation ( include also interventional procedure like ablation , valve replacement etc. ) . Procedures occur prior implantation exclusionary . Expected receive heart transplant ventricular assist device within 6 month Life expectancy le 6 month Participation interventional clinical investigation Pregnant breastfeeding time enrollment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>